Lee’s Pharm is a research-driven and market-oriented biopharmaceutical company with more than 25 years of operation in the pharmaceutical industry in China. The Company is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives. The Company has established extensive partnerships with over 20 international companies and currently markets 23 proprietary, generic and licensed-in pharmaceutical products in Mainland China, Hong Kong, Macau and Taiwan. The company focuses on several key disease areas such as cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics and urology, and has more than 40 products under different development stages stemming from both internal research and development as well as from the licensing and development, commercialisation, and manufacturing rights from various United States, European and Japanese companies. Lee’s Pharm has also involved in the business in ophthalmology through its investment in Zhaoke Ophthalmology Limited, an associated company of the group.
|
|
|
11-50 employees
View all Lee's Pharmaceutical Holdings Limited employees
|
|
Pharmaceuticals
|
|
1st Floor, Building 20E, 20 Science Park East Avenue, Hong Kong Science Park, Shatin, New Territories, HK
|
|
2002
|
Benjamin Li is the CEO of Lee's Pharmaceutical Holdings Limited. To contact Benjamin Li email at [email protected].
The decision makers in Lee's Pharmaceutical Holdings Limited are Abel Xi, Ada Zhang, Benjamin Li, etc. Click to Find Lee's Pharmaceutical Holdings Limited decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.